关于杆细胞蛋白质酶作为药物点的最新情况
1University of California at San Francisco.
Immunology and allergy clinics of North America
|September 27, 2023
概括
乳腺细胞蛋白酶,包括β-tryptases,chymases和 dipeptidyl peptidase-I,是治疗的目标. 抑制剂对喘,性结肠炎和支气管炎有希望,临床试验结果各不相同.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 乳腺细胞在脱粒时从颗粒中释放蛋白酶.
- 这些蛋白酶与各种疾病有关,包括喘,性结肠炎和支气管炎.
- 特定的蛋白酶如β-tryptases,chymases和 dipeptidyl peptidase-I是治疗干预的关键目标.
研究的目的:
- 评估巨细胞蛋白酶抑制剂的治疗潜力.
- 评估针对β-tryptases,chymases和 dipeptidyl peptidase-I的抑制剂的临床疗效和安全性.
主要方法:
- 基于小分子和抗体的抑制剂的临床前研究.
- 针对不同蛋白酶抑制剂的早期阶段和第二阶段人类临床试验.
- 对人类试验对治疗效益和安全性概况的评估.
主要成果:
- β-酸酶抑制剂在临床前表现有希望,并在早期人类试验中显示出一些益处.
- 化学酶抑制剂在第二阶段试验中被安全地使用,但没有显示出显著的益处.
- 双基酸酶-I抑制剂改善了支气管切除,可能是通过使中性粒细胞中的酶失活.
结论:
- 乳腺细胞蛋白酶抑制剂是各种炎症和纤维性疾病的有前途的治疗策略.
- 不同的蛋白酶抑制剂的临床结果各不相同,突出显示了针对特定标的方法的必要性.
- 进一步的研究是有必要的,以优化这些抑制剂的开发和适用于特定条件的应用.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
326
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
326
01:23Role of Matrix Metalloproteases in Degradation of ECM
2.4K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.4K
01:26Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:19Antiasthma Drugs: Leukotriene Modifiers
338
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
338